文献速递显微修复重建创面修复

原发性淋巴水肿显微外科治疗疗效的系统评价

Efficacy of Microsurgical Treatment of Primary Lymphedema: A Systematic Review.
PubMed 文献 · Ann Plast Surg · 2022-01-01

该系统评价检索了2000至2021年PubMed、Scopus和MEDLINE中关于原发性淋巴水肿生理性显微外科治疗的研究,共纳入10项研究、254例患者、357次手术。淋巴静脉吻合占88%,所有研究均显示淋巴水肿有统计学显著改善,认为生理性手术可考虑用于原发性淋巴水肿。

要点

  • 原发性淋巴水肿行生理性显微手术可显著改善肢体周径、水肿体积或生活质量。
  • 淋巴静脉吻合占手术的88%,血管化淋巴结移植的皮瓣除1例外均存活。
  • 基于现有文献,原发性淋巴水肿可考虑生理性显微外科治疗。

核心结论

  • 生理性淋巴外科手术对原发性淋巴水肿患者显示出成功和改善。
  • 基于当前文献,治疗原发性淋巴水肿时应考虑生理性手术治疗。

研究设计与样本

  • 系统评价,检索PubMed、Scopus和MEDLINE,纳入2000至2021年发表的人类研究。
  • 共纳入10项研究,254例原发性淋巴水肿患者,共357次生理性显微手术。
  • 排除仅包含消融或切除手术的研究。

主要发现

  • 淋巴静脉吻合占病例的88%。
  • 接受血管化淋巴结移植的患者中,除1例外所有皮瓣均存活。
  • 无论手术干预类型,所有研究均显示淋巴水肿有统计学显著改善,通过肢体周径缩小、水肿体积减少或生活质量改善体现。

临床怎么用

  • 基于当前文献,原发性淋巴水肿患者可考虑生理性显微外科治疗。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Treatment of lymphedema remains a challenging clinical problem. Lymphatic surgery has recently gained momentum as an effective method to treat both early- and late-stage disease. In particular, "physiologic" microsurgical techniques including vascularized lymph node transplant and lymphovenous bypass/anastomosis have been shown to be effective in treating even advanced lymphedema. Most published reports describe techniques and success in secondary lymphedema. Traditionally, physiologic surgery was not believed to be useful in the treatment of primary lymphedema where baseline lymphatic function is abnormal. However, recent studies have shown a benefit in these cases. The objective of this study is to evaluate outcomes and complications of physiologic microsurgical treatment for primary lymphedema. METHODS: The electronic databases of PubMed, Scopus, and MEDLINE were searched using key words "primary lymphedema" and "surgery" (also vascularized lymph node transplant, lymphovenous bypass, microsurgery). Only human studies published between 2000 and 2021 were included. Studies that only included ablative or resection surgeries were excluded. RESULTS: A total of 10 studies comprising 254 patients with primary lymphedema who underwent 357 physiologic microsurgical operations were included. Lymphovenous bypass comprised 88% of cases, and in the patients who underwent vascularized lymph node transplant, all but 1 flap survived. Regardless of type of operative intervention, all studies showed a statistically significant improvement in lymphedema, through either reduction in limb circumference or edema volume or improvement in quality of life. DISCUSSION: Physiologic lymphatic surgery has shown success and improvement for patients with primary lymphedema. Based on current literature, physiologic surgical treatment of primary lymphedema should be considered when treating this patient population.

来源:Ann Plast Surg,查看原文。版权归原作者所有。

引用

  1. Fallahian F, Tadisina KK, Xu KY, et al. Efficacy of Microsurgical Treatment of Primary Lymphedema: A Systematic Review. Ann Plast Surg. 2022. PMID: 34398594. doi:10.1097/SAP.0000000000002862

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。